Director Global Market Access & Pricing, frexalimab

Director Global Market Access & Pricing, frexalimab

• Location:
  
  Cambridge, MA

Frexalimab is a potential first-in-class anti-CD40L antibody that could change the course of MS by addressing remaining unmet need. With compelling Phase 2 efficacy data and a comprehensive Phase 3 program underway, including 3 clinical studies for RMS and nrSPMS, the program is at a critical point. MS is expected to be the first indication in a broader multi-indication program spanning immunology and metabolic diseases.

The frexalimab Global Market Access & Pricing director role provides an exceptional opportunity to make a tangible difference in patients' lives by contributing to the pricing and market access strategy across RMS and nrSPMS indications and supporting its end-to-end execution. The stakes for this role are high. In a highly competitive MS landscape, frexalimab's ambition to redefine the standard of care demands novel approaches and best-in-class methodologies to unlock its full pricing and access potential in RMS and nrSPMS.

Critically, while this role focuses on MS, the strategic choices made now in MS will set the tone and trajectory for potential follow-on indication's, amplifying the long-term impact of this role well beyond the initial launch.

This is a highly collaborative role, requiring strong cross-functional partnership with Commercial, Medical, Clinical, Evidence for Access, Global Pricing, Biostatistics, Regulatory Affairs, Public Affairs teams, as well as country teams. You'll be part of a high-performing team that values strategic thinking and an unwavering focus on patient access.

This position sits within the Global Market Access & Pricing Neurology Team, which is part of the Specialty Care Global Market Access organization, where collaboration, patient-centricity, and scientific rigor drive everything we do. Our mission is to enable timely access for patients while securing value recognition by external stakeholders, including payers.

Join the team transforming care for people with immune challenges, rare diseases, cancers, and Specialty Care neurological conditions. In Specialty Care, you’ll help deliver breakthrough treatments that bring hope to patients with some of the highest unmet needs.

We're an R&D-driven, AI-powered biopharma company committed to improving people's lives and delivering compelling growth. Our deep understanding of the immune system - and innovative pipeline - enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve people's lives.

• Drive development of key pricing & market access deliverables, including the market access plan, payer value story, global pricing policy informed by pricing research and other data points, contracting strategy, country launch sequencing, negotiation guide, and objection handler
• Play a key role in shaping the MS ecosystem in collaboration with Commercial, Medical, Public Affairs, other global business partners and countries to drive payer value recognition of frexalimab by the time of launch, aiming for sustainable access to innovation
• Generate actionable payer insights through primary research, payer advisory boards, or other platforms to continuously pressure test and refine frexalimab's value proposition and ensure pricing and access strategies are grounded in robust market understanding across markets
• Contribute to the development of frexalimab’s pricing and access MS strategy and scenario planning, in partnership with the Global Brand / Global Project Teams and countries, taking a holistic approach to optimize brand value
• Champion the adoption of digital and AI-enabled tools…